I seem to recall some people crying about 42 day data.. the same DSMB that didn't catch the age imbalance between LLMab and placebo arms wanted to delay the results even more to look at a data point that would've been utterly useless.

Where are those people now, I wonder?

I also think CYDY needs, more than anything, a DSMB that's actually capable of monitoring the study.